Administration of CREON® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: an in vitro study.
Abstract
BACKGROUND AND OBJECTIVES
In clinical practice, the need sometimes arises to administer pancreatic enzyme replacement therapy via gastrostomy tube (G-tube)
by mixing the pellets contained in the capsules with soft food. The objective of this study was to identify G-tubes that allow
administration of pancrelipase gastro-resistant pellets without clogging, sticking, pellet damage or loss of enteric coating
integrity.
METHODS
In this in vitro study, CREON® (pancrelipase) Delayed-Release Capsules were opened and the pellets sprinkled onto a small
amount of baby food of pH <4.5 (applesauce and bananas manufactured by both Gerber and Beech-Nut). The mixture was stirred
gently and after 15 minutes poured into a 35 mL syringe and pushed slowly (~15 mL in 10-15 seconds) through a G-tube. Pellets
were collected and the tube flushed with water. G-tubes were inspected visually for clogging/sticking and damage to pellets
was assessed. If there was none with all four foods, pellet integrity (gastric resistance and lipase activity) was assessed
by an in vitro dissolution method with a 2-hour gastric simulation step. The activity required to confirm integrity was ≥80%
of actual US Pharmacopeia lipase activity per capsule. G-tubes initially tested were Kimberly-Clark MIC Bolus® size 14 French
(Fr) and upwards and Kimberly-Clark MIC-KEY® 14 Fr and upwards. Following successful testing, assessment of Bard® Tri-Funnel
18 Fr and Bard® Button 18 Fr G-tubes was carried out.
RESULTS
Based on the absence of clogging, sticking and visible damage to pellets, and the maintenance of pellet integrity, administration
of CREON® pancrelipase pellets was feasible through the following G-tubes: Kimberly-Clark MIC Bolus® size 18 Fr, Kimberly-Clark
MIC-KEY® 16 Fr, Bard® Tri-Funnel 18 Fr and Bard® Button 18 Fr. Lipase activity met the predetermined specification and was
≥90% for all four tubes and all four foods, with no differences versus untreated pellets (i.e. pellets not mixed with baby
food or pushed through a G-tube). These data apply to all CREON® pancrelipase capsule formulations, regardless of their strength
in lipase units, as pellet composition, size and quality are identical.
CONCLUSION
CREON® pancrelipase pellets can be mixed with baby food of pH <4.5 and administered via the following G-tubes without clogging,
sticking or visible pellet damage, and with no loss of gastric resistance or lipase activity: Kimberly-Clark MIC Bolus® size
18 Fr and larger, Kimberly-Clark MIC-KEY® 16 Fr and larger, Bard® Tri-Funnel 18 Fr and larger and Bard® Button 18 Fr and larger.
Links
Authors
Shlieout G, Koerner A, Maffert M, Forssmann K, Caras S
Institution
Abbott, Hannover, Germany. george.shlieout@abbott.com
Source
Clinical drug investigation 31:7 2011 pg e1-7MeSH
Delayed-Action PreparationsDrug Implants
Enteral Nutrition
Enzyme Replacement Therapy
Enzyme Stability
Feasibility Studies
Food
Pancrelipase
Solubility
Pub Type(s)
In VitroJournal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
21627335
Log In

